ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023
Impact of the COVID-19 Pandemic on Cancer Screening Delays.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Hospital-based gastric cancer outcomes in the United States (2003-2022): racial and regional disparities.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026Article
- Article
- Paleopathology Meets Public Health: Deep-Time Syndemics and the Ecology of Emerging Infections.Pathogens (Basel, Switzerland) · 2026Review
- Rural-urban differences in cancer worry, beliefs, and attitudes towards research progress.Cancer causes & control : CCC · 2026Article
- Delayed diagnostic imaging but stable treatment initiation for kidney cancer during the COVID-19 pandemic: a Hungarian cohort study.Pathology oncology research : POR · 2026Article
- Changes in oncological surgical volume and postoperative survival during the COVID-19 pandemic: a retrospective multicenter study in a regional German hospital network.Frontiers in oncology · 2026Article
- Differences in COVID-19 preventive behaviors among Black and White cancer survivors in North Carolina.Journal of cancer survivorship : research and practice · 2025Article
- 'I don't know when it's my turn': reasons for low uptake of cancer-related healthcare services in Germany.BMC public health · 2025Article
- Health Services Usage in Patients Receiving Buprenorphine for Opioid Use Disorder or Long-Term Opioid Therapy for Chronic Pain: Retrospective Cohort Study.JMIR formative research · 2025Article
- Eligibility for and reach of the National Breast and Cervical Cancer Early Detection Program, 2018-2021.Cancer causes & control : CCC · 2025Article
- Changes in Breast and Cervical Cancer Incidence by Stage at Diagnosis During the COVID-19 Pandemic in Utah.Cancer medicine · 2025Article
- Article
- Recovery From COVID-19-Related Disruptions in Cancer Detection.JAMA network open · 2024Article
- COVID-19 and Rates of Cancer Diagnosis in the US.JAMA network open · 2024Article
- Investigating socioeconomic disparities in lung cancer diagnosis, treatment and mortality: an Italian cohort study.BMC public health · 2024Observational
- Perspectives of patients undergoing neoadjuvant chemotherapy for breast cancer during the COVID-19 pandemic.Cancer reports (Hoboken, N.J.) · 2023Article
- Updated COVID-19 clearance time among patients with cancer in the Delta and Omicron waves.Cancer medicine · 2023Article
- Associations between cancer history, social distancing behaviors, and loneliness in adults during the COVID-19 pandemic.PloS one · 2023Article
- Cancer statistics for Hispanic/Latino people, 2026.CA: a cancer journal for cliniciansArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeTo examine delays in cancer screenings during the COVID-19 pandemic.
methodsParticipants from previous studies (N = 32,989) with permissions to be recontacted were invited to complete a survey between June and November 2020. Participants (n = 7,115) who met the age range for cancer screenings were included. Participants were asked if they planned to have and then if they postponed a scheduled mammogram, Pap test, stool blood test, colonoscopy, or human papillomavirus (HPV) test. Logistic regression was used to determine the factors associated with cancer screening delays for each planned test.
resultsThe average age was 57.3 years, 75% were female, 89% were non-Hispanic White, 14% had public insurance, and 34% lived in rural counties. Those who planned cancer screenings (n = 4,266, 60%) were younger, more likely to be female, with higher education, had private insurance, and lived in rural counties. Specifically, 24% delayed a mammogram (n = 732/2,986), 27% delayed a Pap test (n = 448/1,651), 27% delayed an HPV test (n = 59/220), 11% delayed a stool blood test (n = 44/388), and 36% delayed a colonoscopy (n = 304/840). Age, race/ethnicity, education, and health insurance were associated with delays in cancer screenings (all
conclusionOur findings highlighted the urgency for health care providers to address the significant delays in cancer screenings in those most likely to delay. Strategies and resources are needed to help those with barriers to receiving guideline-appropriate cancer screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.